PMID- 19524871 OWN - NLM STAT- MEDLINE DCOM- 20091001 LR - 20141120 IS - 1931-5244 (Print) IS - 1878-1810 (Linking) VI - 154 IP - 1 DP - 2009 Jul TI - Stimulation of CCL2 (MCP-1) and CCL2 mRNA by substance P in LAD2 human mast cells. PG - 27-33 LID - 10.1016/j.trsl.2009.03.006 [doi] AB - Chemokines are cytokines with chemotactic properties on inflammatory cells and other cell types. Chemokine (C-C motif) ligand 2 (CCL2), which is also called monocyte chemotactic protein 1 (MCP-1), is a potent chemotactic molecule that attracts lymphocytes, monocytes, mast cells, and memory T cells, but not neutrophils. CCL2/MCP-1 represents a link between the activation of monocytes, lymphocytes, basophils, mast cells, and eosinophils in inflammatory disorders, such as the late-phase allergic reaction. This C-C chemokine also plays a role in regulating Th-cell cytokine production and leukocyte trafficking. Laboratory of allergic diseases (LAD) cells is the first reported human mast cell line that closely resembles a primary culture of CD34+-derived human mast cells. These cells were cultured in vitro and treated with different concentrations of substance P (SP) for the production of CCL2/MCP-1. We used calcium ionophore as a positive control for stimulating transcription and translation of CCL2/MCP-1. The stimulation of SP on CCL2/MCP-1 was statistically significant (P < 0.05) compared with the control (untreated cells). In this study, we determined the expression and secretion of CCL2/MCP-1 from SP-activated LAD2 human mast cells in vitro. The levels of CCL2/MCP-1 from SP-activated LAD2 human mast cells were higher at 10 microM and at 18 h incubation compared with controls. This effect was also revealed on CCL2/MCP-1 messenger RNA (mRNA) expression, as determined by reverse transcriptase polymerase chain reaction (RT-PCR) analysis. Our data suggest that SP is an important neurotransmitter that can stimulate the chemokine CCL2, which plays a fundamental role in inflammation by recruiting inflammatory cells to specific cites. FAU - Castellani, Maria Luisa AU - Castellani ML AD - Immunology Division, Medical School, University of Chieti-Pescara, Chieti, Italy. FAU - Vecchiet, Jacopo AU - Vecchiet J FAU - Salini, Vincenzo AU - Salini V FAU - Conti, Pio AU - Conti P FAU - Theoharides, Theoharis C AU - Theoharides TC FAU - Caraffa, Auro AU - Caraffa A FAU - Antinolfi, Pierluigi AU - Antinolfi P FAU - Tete, Stefano AU - Tete S FAU - Ciampoli, Cristian AU - Ciampoli C FAU - Cuccurullo, Chiara AU - Cuccurullo C FAU - Cerulli, Giuliano AU - Cerulli G FAU - Felaco, Mario AU - Felaco M FAU - Boscolo, Paolo AU - Boscolo P LA - eng PT - Journal Article DEP - 20090422 PL - United States TA - Transl Res JT - Translational research : the journal of laboratory and clinical medicine JID - 101280339 RN - 0 (CCL2 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (RNA, Messenger) RN - 33507-63-0 (Substance P) SB - IM MH - Cell Line MH - Chemokine CCL2/*genetics MH - Chemotaxis, Leukocyte/drug effects/physiology MH - Dose-Response Relationship, Drug MH - Humans MH - In Vitro Techniques MH - Mast Cells/*drug effects/*physiology MH - RNA, Messenger/metabolism MH - Reverse Transcriptase Polymerase Chain Reaction MH - Substance P/*pharmacology EDAT- 2009/06/16 09:00 MHDA- 2009/10/02 06:00 CRDT- 2009/06/16 09:00 PHST- 2008/09/22 00:00 [received] PHST- 2009/03/22 00:00 [revised] PHST- 2009/03/23 00:00 [accepted] PHST- 2009/06/16 09:00 [entrez] PHST- 2009/06/16 09:00 [pubmed] PHST- 2009/10/02 06:00 [medline] AID - S1931-5244(09)00083-8 [pii] AID - 10.1016/j.trsl.2009.03.006 [doi] PST - ppublish SO - Transl Res. 2009 Jul;154(1):27-33. doi: 10.1016/j.trsl.2009.03.006. Epub 2009 Apr 22.